BASI vs. BIAF, AIKI, NOTV, TXMD, APM, AIH, OCX, BFRG, TTOO, and PYPD
Should you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Inotiv (NOTV), TherapeuticsMD (TXMD), Aptorum Group (APM), Aesthetic Medical International Holdings Group (AIH), OncoCyte (OCX), Bullfrog AI (BFRG), T2 Biosystems (TTOO), and PolyPid (PYPD). These companies are all part of the "medical" sector.
bioAffinity Technologies (NASDAQ:BIAF) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.
Bioanalytical Systems has a net margin of -7.75% compared to Bioanalytical Systems' net margin of -171.43%. bioAffinity Technologies' return on equity of -42.74% beat Bioanalytical Systems' return on equity.
1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are owned by institutional investors. 36.4% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Bioanalytical Systems has higher revenue and earnings than bioAffinity Technologies. Bioanalytical Systems is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.
bioAffinity Technologies has a beta of 3.15, suggesting that its share price is 215% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500.
In the previous week, bioAffinity Technologies had 3 more articles in the media than Bioanalytical Systems. MarketBeat recorded 3 mentions for bioAffinity Technologies and 0 mentions for Bioanalytical Systems. bioAffinity Technologies' average media sentiment score of 0.00 beat Bioanalytical Systems' score of -0.32 indicating that Bioanalytical Systems is being referred to more favorably in the news media.
Bioanalytical Systems received 128 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.
Summary
Bioanalytical Systems beats bioAffinity Technologies on 9 of the 14 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bioanalytical Systems Competitors List
Related Companies and Tools
